A Neck Mass in a Patient Who Declines Excision
A 52-year-old man presents with a 2.4 cm firm, nontender left level II neck mass that has enlarged over 6 weeks. He has smoked 1 pack/day for 30 years and reports 3 episodes of scant blood-tinged sputum but no dysphagia or hoarseness. Flexible laryngoscopy shows a normal mucosa over the left base of tongue and a normal pyriform sinus. Fine-needle aspiration of the node shows keratinizing squamous cells and abundant anucleate squames with rare neutrophils; no viable lymphocytes are seen. The cytopathologist flags this as nondiagnostic/indeterminate because keratin can mimic a cystic squamous metastasis. The patient is anxious and asks whether the node can simply be observed and re-imaged in 3 months. He has no prior head and neck cancer, no skin cancer history, and no systemic symptoms.
1. Interpret the FNA findings and explain why a purely keratinous aspirate from a level II neck node in this patient cannot be dismissed as a benign branchial cleft cyst.
Read the worked answer
The aspirate contains only keratinized squamous material and rare neutrophils with no lymphoid component. A true branchial cleft cyst aspirate should show a mixed population of mature lymphocytes and possibly cholesterol crystals in a proteinaceous background; the absence of lymphocytes argues against a simple cyst. In a 52-year-old smoker with a persistent level II mass, keratinizing squamous material is far more likely to represent a cystic metastasis from an occult mucosal squamous cell carcinoma, particularly from the base of tongue or tonsil, which can produce cystic nodal metastases with a deceptively bland keratin-rich aspirate. The negative laryngoscopy does not exclude this because the primary may be small, submucosal, or in a cryptic site. The correct conclusion is that the FNA is indeterminate and requires tissue correlation, not that the lesion is benign.
2. Given the patient's wish to observe, outline the next diagnostic steps and justify why observation is unsafe.
Read the worked answer
Observation is unsafe because a persistent level II mass in a high-risk smoker is cancer until proven otherwise, and delay risks upstaging and loss of de-escalated treatment options. Next steps: (1) repeat FNA with ultrasound guidance and, if any fluid is obtained, send it for cell block and p16 immunohistochemistry; (2) core needle biopsy or excisional biopsy of the node for architecture and p16/HPV testing; (3) if squamous carcinoma is confirmed, perform a PET-CT and bilateral tonsillectomy with base-of-tongue biopsies to find the primary; (4) panendoscopy with directed biopsies. The key judgment is that a nondiagnostic keratinous aspirate is an indication for further sampling, not reassurance.
3. The node biopsy later shows p16-positive nonkeratinizing squamous cell carcinoma. How does this change the working diagnosis and the search for a primary?
Read the worked answer
p16 positivity in a nonkeratinizing squamous carcinoma of the neck strongly suggests HPV-associated oropharyngeal carcinoma, most often tonsillar or base of tongue. The search should focus on the oropharynx: bilateral palatine tonsillectomy and base-of-tongue biopsies are the standard next step even when the mucosa looks normal, because the primary is frequently submucosal or buried in crypts. A PET-CT may show the primary or identify other disease. The p16 status also carries prognostic and staging implications under HPV-mediated oropharyngeal staging systems, and it changes treatment planning toward definitive chemoradiation rather than primary surgery in many cases. The initial keratinizing FNA material and the final nonkeratinizing p16-positive tissue illustrate that morphology alone can mislead and that ancillary testing is essential.